Vaginal CO2 Laser (MonaLisa Touch) in Mexico City
Dryness, burning and pain during intercourse after menopause have a name and have treatment, even if you cannot or do not want to use hormones.
What it is and how it works
genitourinary syndrome of menopause occurs because, as estrogen declines, the vaginal lining thins, loses elasticity, dries out and changes its pH. That produces dryness, burning, itching, pain during intercourse and sometimes urinary symptoms. MonaLisa Touch is a fractional CO2 laser with a vaginal probe designed specifically for this: it delivers microcolumns of energy into the vaginal wall that stimulate new collagen formation and epithelial regeneration, improving tissue thickness, hydration and pH.
What it treats, in detail
- Vaginal dryness.
- Burning, itching and irritation.
- Pain during sexual intercourse.
- Lack of lubrication and its impact on sexual life.
- Laxity of the vaginal wall.
- Associated mild urinary symptoms, such as urgency or frequency.
- It is especially relevant for women who cannot use estrogen, for example after breast cancer with anti-estrogen treatment.
How we do it here
first, this is not treated as an aesthetic procedure, it is treated as what it is, a medical problem. That is why we assess the case together with the gynecologist: before treating, the diagnosis must be confirmed, other causes of the symptoms ruled out, and first-line treatments reviewed, such as moisturizers, lubricants or low-dose vaginal estrogen when indicated. Our device is the Deka SmartXide with the MonaLisa Touch module, the same system used in the published studies on this indication. The usual protocol is three sessions, each under 10 minutes, several weeks apart, with subsequent maintenance.
Who it’s for
women in menopause or perimenopause with genitourinary symptoms, women with surgical menopause, and particularly women who cannot use hormone therapy, such as breast cancer survivors on anti-estrogen treatment, where options are limited.
Who it’s not for
we do not treat with active or recurrent genital infection, with unexplained bleeding, during pregnancy, with advanced prolapse, or with recent pelvic reconstructive surgery. And if your symptoms are not due to atrophy but another cause, that is investigated first.
What to expect
- 01
the session is outpatient, lasts under 10 minutes and usually requires no anesthesia; most patients describe it as a vibration or mild warmth.
- 02
We will ask for a few days of sexual abstinence and avoidance of tampons and baths during that period.
- 03
Many patients notice improvement from the first session, the effect accumulates over the following months, and the reported duration of benefit ranges from 9 to 16 months, so maintenance is usually required.
Risks and what we tell you honestly
here we want to be especially transparent, because this is an area where too much is promised. Usual effects are mild discomfort, a sensation of warmth and light discharge for a few days. Now, about the evidence: there are positive studies, including a double-blind sham-controlled trial where the laser outperformed the control for symptoms such as dryness and painful intercourse. But the other side must also be said: the most recent meta-analyses conclude that the benefit attenuates when compared against sham, and that the certainty of the evidence remains limited. In a specific trial in breast cancer survivors, three sessions did not differ from sham, and six sessions showed modest improvement that did not reach clinical significance. Long-term duration of effect, urinary effects and direct comparison against low-dose vaginal estrogen are still not well defined. That is why we present it as a valid option, especially when you cannot use hormones, and not as a guaranteed solution.
Beyond aesthetics
this is not aesthetics, it is quality of life. Genitourinary atrophy does not improve on its own: it is progressive, and untreated it can lead to vaginal narrowing, pelvic pain from anticipatory muscle contracture, and recurrent urinary infections. The impact on sexual life and on a relationship is real, and many women stay silent about it for years because they believe it is an inevitable part of aging.
Myth vs reality
Myth
“It is normal at my age, there is nothing to be done.”
Reality
it is common, but not something you have to endure. Up to 57% of breast cancer survivors experience it, and in the general postmenopausal population it is even more common. There are first-line treatments, there are local hormonal options when indicated, and there is this option when hormones are not possible or were not enough. What makes no sense is not raising it.
Book your consultation and we will review it together with our gynecologist.
This consultation carries a fee, which is not credited toward treatment.
Advisory session with our teamComplimentary. We answer questions about process, estimated pricing and travel logistics.